BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1704305)

  • 1. [Quantitative determination of 7 proteins in csf of patients with Guillain Barre syndrome].
    Li YT
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Oct; 23(5):289-92, 319-20. PubMed ID: 1704305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related alterations of the blood-brain-barrier (bbb) permeability to protein molecules of different size.
    Kleine TO; Hackler R; Zöfel P
    Z Gerontol; 1993; 26(4):256-9. PubMed ID: 7692679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebrospinal fluid IgG, IgA and IgM in healthy controls and in patients with Guillain-Barré syndrome (author's transl)].
    Kobatake K
    Rinsho Shinkeigaku; 1981 Jul; 21(7):619-27. PubMed ID: 7307403
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunoglobulins in serum and cerebrospinal fluid from patients with acute Guillain-Barré syndrome.
    Vedeler CA; Matre R; Nyland H
    Acta Neurol Scand; 1986 Apr; 73(4):388-93. PubMed ID: 3727914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laser nephelometric evaluation of albumin, IgG and alpha 2-macroglobulin: applications to the study of alterations of the blood-brain barrier.
    Meucci G; Rossi G; Bettini R; Montanaro D; Gironelli L; Voci L; Bianchi F
    J Neurol Sci; 1993 Aug; 118(1):73-8. PubMed ID: 7693877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa/lambda ratios of IgG, IgA and IgM in the cerebrospinal fluid of patients with Guillain-Barré syndrome.
    Araga S; Kagimoto H; Adachi A; Funamoto K; Inoue K; Takahashi K
    Jpn J Med; 1991; 30(2):118-22. PubMed ID: 1907691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative immunochemical studies of ten individual proteins in the cerebrospinal fluid of children with acute inflammatory meningeal diseases].
    Wiedermann D; Wiedermannová D; Cídl K; Macků M
    Helv Paediatr Acta; 1973 Jul; 28(3):221-9. PubMed ID: 4198876
    [No Abstract]   [Full Text] [Related]  

  • 8. CSF immunoglobulins and viral antibodies in acute transverse myelitis and Guillain-Barre syndrome.
    Wadia RS; Ghosh SN; Gulavani AV; Sardesai HV; Ambekar N; Ayachit VL
    Neurol India; 1978 Sep; 26(3):118-22. PubMed ID: 745669
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cerebrospinal fluid parameters in Guillain-Barré polyradiculitis. Importance of barrier disorder and intrathecal immunoglobulin synthesis].
    Papen R; Warecka K
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jun; 41(6):334-43. PubMed ID: 2772069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of immunoglobulins G, A, M, alpha-2-macroglobulin and ceruloplasmin levels in cerebrospinal fluid of children and adults by a nephelometric laser method (author's transl)].
    di Costanzo J; Romette J; Lévy G; Gulian JM; Arnaud C; Ciret P
    Ann Biol Clin (Paris); 1980; 38(4):231-5. PubMed ID: 6160784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of proteins in cerebrospinal fluid of adults using two immunochemical methods (author's transl)].
    Romette J; Levy G; Dicostanzo J; Garçon D; Boudouresques G
    Clin Chim Acta; 1979 Jun; 94(2):121-4. PubMed ID: 88285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific serum protein levels in women using intrauterine contraceptive device.
    Wiedermann D; Kríz J; Cídl K
    Czech Med; 1980; 3(3):239-47. PubMed ID: 6969168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpesvirus serology in patients with Guillain-Barré syndrome.
    Link H; Wahren B; Norrby E
    J Clin Microbiol; 1979 Mar; 9(3):305-16. PubMed ID: 222797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Quantitative determination of immunoglobulins, haptoglobin, transferrin and ceruloplasmin in cerebrospinal fluid. Preliminary note].
    Ferlito S; Reggio A; Pero G; Nicoletti F
    Acta Neurol (Napoli); 1973; 28(1):35-46. PubMed ID: 4634160
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated serum levels of tumor necrosis factor-alpha in Guillain-Barré syndrome.
    Sharief MK; McLean B; Thompson EJ
    Ann Neurol; 1993 Jun; 33(6):591-6. PubMed ID: 8498839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A variant form of Guillain-Barre syndrome: a study of clinical and pathology of sural nerve biopsy].
    Guo YP
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Dec; 24(6):326-9, 382. PubMed ID: 1800055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The content of the protein markers of hemato-encephalic barrier permeability in the cerebrospinal fluid in severe craniocerebral trauma].
    Kuksinskiĭ VA; Lutsik AA; Churliaev IuA; Lykova OF; Nikiforova NV; Martynenkov VIa; Bykov KV
    Zh Vopr Neirokhir Im N N Burdenko; 1998; (2):26-7. PubMed ID: 9720164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum glycoproteins in autoimmune diseases.
    Jakab L; Pozsonyi T; Fehér J
    Acta Med Acad Sci Hung; 1976; 33(2):161-9. PubMed ID: 71842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein distribution across the human atherosclerotic wall with reference to immunoglobulins and complement components.
    Vlaicu R; Rus HG; Niculescu F; Cristea A
    Med Interne; 1985; 23(2):87-94. PubMed ID: 2410972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological observations in Guillain-Barré syndrome.
    Sepcić J; Morović M; Rukavina D; Sepić-Grahovac D
    Acta Med Iugosl; 1990; 44(4):265-74. PubMed ID: 2091432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.